In vitro Treg suppression assays
- PMID: 21287326
- PMCID: PMC3043080
- DOI: 10.1007/978-1-61737-979-6_2
In vitro Treg suppression assays
Abstract
Determining the activity of a regulatory T-cell population in vitro is often the first step in analyzing its function. To obtain reliable and reproducible results, it is critical to follow the protocol that is most applicable to your experimental question. We have outlined below a basic in vitro suppression assay as well as a variety of alternative/additional protocols that can be utilized alone or in combination as desired.
Figures
References
-
- Takahashi T, Kuniyasu Y, Toda M, Sakaguchi N, Itoh M, Iwata M, Shimizu J, Sakaguchi S. Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int Immunol. 1998;10:1969–1980. - PubMed
-
- Annacker O, Pimenta-Araujo R, Burlen-Defranoux O, Bandeira A. On the ontogeny and physiology of regulatory T cells. Immunol Rev. 2001;182:5–17. - PubMed
-
- Belkaid Y, Piccirillo CA, Mendez S, Shevach EM, Sacks DL. CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature. 2002;420:502–507. - PubMed
Publication types
MeSH terms
Grants and funding
- R01 AI039480/AI/NIAID NIH HHS/United States
- F32 AI072816/AI/NIAID NIH HHS/United States
- AI39480/AI/NIAID NIH HHS/United States
- AI52199/AI/NIAID NIH HHS/United States
- R01 AI052199/AI/NIAID NIH HHS/United States
- R01 AI091977/AI/NIAID NIH HHS/United States
- R21 AI052199/AI/NIAID NIH HHS/United States
- R56 AI052199/AI/NIAID NIH HHS/United States
- CA21765/CA/NCI NIH HHS/United States
- AI072239/AI/NIAID NIH HHS/United States
- P30 CA021765/CA/NCI NIH HHS/United States
- R01 CA203689/CA/NCI NIH HHS/United States
- R29 AI039480/AI/NIAID NIH HHS/United States
- R56 AI072239/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
